Health Condition 1: D259- Leiomyoma of uterus, unspecified
Conditions
Interventions
Intervention1: EPIHYSTERINUM 30/200/1M: Medicine will be given in 1 dose by oral route based on the follow up done at 15 days interval over a duration till the patient is not cured within 1 year of r
Sponsors
RBTS GOVT HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITAL
Eligibility
Inclusion criteria
Inclusion criteria: Self reported and prediagnosed cases of Uterine Fibroids. Patients with symptomatology of Uterine Fibroids. Cases confirmed by USG or Laproscopy. Uterine fibroid of size less than 12 weeks
Exclusion criteria
Exclusion criteria: Patients or its guardian unwilling to take part or not giving consent to join the study. Diagnosed cases of systemic diseases psychiatric illness or other uncontrolled or life threatening illness affecting quality of life or any organ failure. Substance abuse and or dependence. Self reported immunecompromised state. Uterine Fibroid of size more than 12 weeks Persistent uterine bleeding despite medical therapy Excessive pain or pressure symptoms Recurrent pregnancy loss due to fibroid/or Rapidly growing myoma
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in their symptomatology. Improvement in Aberdeen Menorrhagia Severity Scale(AMSS) score. Timepoint: 0-3 MONTHS | — |
Secondary
| Measure | Time frame |
|---|---|
| uterine fibroids Symptom and Quality of life UFSQOLTimepoint: 0-6 MONTHS | — |
Countries
India
Contacts
Public ContactDR NIRBHAY KUMAR
RBTS Govt Hom Medical College and Hospital
Outcome results
None listed